MedTrace Logo

FuRST 2.0 Cognitive Pre-Testing

NCT02881931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2017-08-08

No results posted yet for this study

Summary

The FuRST 2.0 scale is being developed as a Patient Reported Outcome (PRO) with information coming directly from the Huntington's Disease Gene Expansion Carrier (HDGEC) and companion through self-report. The purpose of this study is to identify real or potential comprehension or usage problems with questionnaire items or response options. Through a process of structured cognitive de-briefing with HDGEC participants and companions, independently, followed by qualitative analysis, the final phrasing of the individual items and response options for the scale will be generated. Depending on the results of the first round of cognitive pre-testing, additional rounds of cognitive pre-testing may be required.

Conditions

Interventions

BEHAVIORAL

FuRST 2.0

Cognitive Pre-testing of new Functional Rating Scale

Sponsors & Collaborators

  • Dr. Glenn T. Stebbins (Rush University Medical Center )

    collaborator UNKNOWN

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Nancy LaPelle

    collaborator UNKNOWN

  • CHDI Foundation, Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2017-07-28
Completion
2017-07-28

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881931 on ClinicalTrials.gov